These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34688293)

  • 1. Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer.
    Peng J; Li W; Fan W; Zhang R; Li X; Xiao B; Dong Y; Wan D; Pan Z; Lin J; Wu X
    Cancer Cell Int; 2021 Oct; 21(1):554. PubMed ID: 34688293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring prognostic values of DNA ploidy, stroma-tumor fraction and nucleotyping in stage II colon cancer patients.
    Lou Y; Yang L; Xu S; Tan L; Bai Y; Wang L; Sun T; Zhou L; Feng L; Lian S; Wu A; Li Z
    Discov Oncol; 2024 Jun; 15(1):227. PubMed ID: 38874696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer.
    Peng J; Zhang W; He J; Wang W; Li W; Mao L; Dong Y; Lu Z; Pan Z; Zhou C; Wu X
    Ther Adv Med Oncol; 2024; 16():17588359241260575. PubMed ID: 38894737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
    Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
    PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer.
    Yang L; Chen P; Zhang L; Wang L; Sun T; Zhou L; Li Z; Wu A
    Br J Cancer; 2020 Sep; 123(6):973-981. PubMed ID: 32624576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.
    Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases.
    Liao L; Sun H; He J; Liu Y; Pan Z; Wu X; Fan W; Peng J; Li C
    BMC Surg; 2023 Sep; 23(1):271. PubMed ID: 37689651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
    Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
    J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Chromatin Structure Typing in Early-Stage Non-Small Cell Lung Cancer.
    Mao L; Wu J; Zhang Z; Mao L; Dong Y; He Z; Wang H; Chi K; Jiang Y; Lin D
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 11. Automated assessment of DNA ploidy, chromatin organization, and stroma fraction to predict prognosis and adjuvant therapy response in patients with stage II colorectal carcinoma.
    Zhao Z; Zhang X; Li Z; Gao Y; Guan X; Jiang Z; Liu Z; Yang M; Chen H; Ma X; Yang R; Lu Z; Liu H; Yang L; Wu A; Zou S; Wang X
    Am J Cancer Res; 2021; 11(12):6119-6132. PubMed ID: 35018246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases.
    Chen ZG; Ji XM; Xu YX; Fong WP; Liu XY; Liang JY; Tan Q; Wen L; Cai YY; Wang DS; Li YH
    Ther Adv Med Oncol; 2024; 16():17588359241230752. PubMed ID: 38425989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of infracentimetric colorectal liver metastases.
    Frosio F; Cervantes B; Nassar A; Faermark N; Sanou Y; Bonnet S; Lefevre M; Louvet C; Gayet B; Fuks D
    Langenbecks Arch Surg; 2022 Aug; 407(5):1971-1980. PubMed ID: 35347398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
    Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
    BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study.
    Kelm M; Schollbach J; Anger F; Wiegering A; Klein I; Germer CT; Schlegel N; Kunzmann V; Löb S
    BMC Cancer; 2021 May; 21(1):490. PubMed ID: 33941104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers for colorectal cancer: estimating ploidy and stroma.
    Danielsen HE; Hveem TS; Domingo E; Pradhan M; Kleppe A; Syvertsen RA; Kostolomov I; Nesheim JA; Askautrud HA; Nesbakken A; Lothe RA; Svindland A; Shepherd N; Novelli M; Johnstone E; Tomlinson I; Kerr R; Kerr DJ
    Ann Oncol; 2018 Mar; 29(3):616-623. PubMed ID: 29293881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of resectable colorectal liver metastases after surgery associated with pathological features of primary tumor.
    Chen D; Li Q; Yu H
    Front Oncol; 2023; 13():1181522. PubMed ID: 37305574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases.
    Yoshimoto T; Morine Y; Imura S; Ikemoto T; Iwahashi S; Saito YU; Yamada S; Ishikawa D; Teraoku H; Yoshikawa M; Higashijima J; Takasu C; Shimada M
    In Vivo; 2017; 31(3):419-423. PubMed ID: 28438872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation.
    Chen Y; Chang W; Ren L; Chen J; Tang W; Liu T; Jian M; Liu Y; Wei Y; Xu J
    Oncologist; 2020 Jul; 25(7):e1031-e1041. PubMed ID: 32181531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer.
    Li Y; Liao L; Kong L; Jiang W; Tang J; Han K; Hou Z; Zhang C; Zhou C; Zhang L; Sui Q; Xiao B; Mei W; Xu Y; Yu J; Hong Z; Pan Z; Ding P
    Clin Transl Oncol; 2023 Jan; 25(1):218-225. PubMed ID: 36076121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.